Literature DB >> 12752285

Radical lymph node dissection for melanoma.

Jonathan W Serpell1, Peter W G Carne, Michael Bailey.   

Abstract

BACKGROUND: Therapeutic lymph node dissection for melanoma aims to achieve regional disease control. Radical lymphadenectomy (RLND) can be a difficult procedure associated with significant postoperative morbidity. The aims of the present study were to review regional disease control and morbidity in a series of lymphadenectomies performed within a specialist unit.
METHODS: The present study involved the analysis of 73 lymphadenectomies in 64 patients, from 1995 to 2001.
RESULTS: The overall wound complication rate after inguinal lymphadenectomy (71%) was higher than after axillary lymphadenectomy (47%; P = 0.05). After inguinal lymphadenectomy, the wound infection rate was higher (25.0%vs 5.9%; P = 0.03), delayed wound healing was more frequent (25.0%vs 5.9%; P = 0.03), and the mean time that drain tubes remained in situ was longer (12.5 vs 8.2 days; P = 0.05). There were no significant differences in seroma (46%vs 32%) rates. Lymphoedema was more common after inguinal lymphadenectomy (P < 0.02). Multivariate analysis identified inguinal RLND (P = 0.002) and increasing tumour size (P = 0.045) as predictors of wound morbidity. More patients received postoperative radiotherapy after neck RLND compared to inguinal or axilla RLND (P = 0.03). Six (8%) patients developed local recurrence after lymphadenectomy. At a median follow up of 22 months, 34 (53%) patients have died, from disseminated disease.
CONCLUSIONS: Radical lymphadenectomy for melanoma is associated with significant morbidity. Inguinal node dissection has a higher rate of complications than axillary dissection. Low local recurrence rates can be achieved, limiting the potential morbidity of uncontrolled regional metastatic disease.

Entities:  

Mesh:

Year:  2003        PMID: 12752285     DOI: 10.1046/j.1445-2197.2003.t01-1-02622.x

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  19 in total

1.  Risk evaluation in cutaneous melanoma patients undergoing lymph node dissection: impact of POSSUM.

Authors:  F Egberts; C Hartje; C Schafmayer; K C Kaehler; W von Schönfels; A Hauschild; T Becker; J H Egberts
Journal:  Ann R Coll Surg Engl       Date:  2011-10       Impact factor: 1.891

2.  Prospective assessment of postoperative complications and associated costs following inguinal lymph node dissection (ILND) in melanoma patients.

Authors:  Sharon B Chang; Robert L Askew; Yan Xing; Storm Weaver; Jeffrey E Gershenwald; Jeffrey E Lee; Richard Royal; Anthony Lucci; Merrick I Ross; Janice N Cormier
Journal:  Ann Surg Oncol       Date:  2010-03-25       Impact factor: 5.344

3.  Effectiveness of intraoperative indocyanine-green fluorescence angiography during inguinal lymph node dissection for skin cancer to prevent postoperative wound dehiscence.

Authors:  Hiroshi Furukawa; Toshihiko Hayashi; Akihiko Oyama; Emi Funayama; Naoki Murao; Takeshi Yamao; Yuhei Yamamoto
Journal:  Surg Today       Date:  2014-07-26       Impact factor: 2.549

4.  Frequency of level II and III axillary nodes metastases in patients with positive sentinel lymph nodes in melanoma: a multi-institutional study in Japan.

Authors:  Arata Tsutsumida; Akira Takahashi; Kenjiro Namikawa; Naoya Yamazaki; Hisashi Uhara; Yukiko Teramoto; Tatsuya Takenouchi; Satoshi Fukushima; Kenji Yokota; Jiro Uehara; Shigeto Matsushita; Yoshitsugu Shibayama; Naohito Hatta; Yuri Masui; Hiroshi Uchi; Yasuhiro Fujisawa; Dai Ogata
Journal:  Int J Clin Oncol       Date:  2016-01-13       Impact factor: 3.402

5.  Successful doxycycline treatment of lymphatic fistulas: report of five cases and review of the literature.

Authors:  Thilo Hackert; Jens Werner; Martin Loos; Markus W Büchler; Jürgen Weitz
Journal:  Langenbecks Arch Surg       Date:  2006-05-09       Impact factor: 3.445

6.  The long-term risk of upper-extremity lymphedema is two-fold higher in breast cancer patients than in melanoma patients.

Authors:  Rachel K Voss; Kate D Cromwell; Yi-Ju Chiang; Jane M Armer; Merrick I Ross; Jeffrey E Lee; Jeffrey E Gershenwald; Bob R Stewart; Simona F Shaitelman; Janice N Cormier
Journal:  J Surg Oncol       Date:  2015-10-18       Impact factor: 3.454

7.  Safety and Feasibility of Minimally Invasive Inguinal Lymph Node Dissection in Patients With Melanoma (SAFE-MILND): Report of a Prospective Multi-institutional Trial.

Authors:  James W Jakub; Alicia M Terando; Amod Sarnaik; Charlotte E Ariyan; Mark B Faries; Sabino Zani; Heather B Neuman; Nabil Wasif; Jeffrey M Farma; Bruce J Averbook; Karl Y Bilimoria; Travis E Grotz; Jacob B Jake Allred; Vera J Suman; Mary Sue Brady; Douglas Tyler; Jeffrey D Wayne; Heidi Nelson
Journal:  Ann Surg       Date:  2017-01       Impact factor: 12.969

8.  Dominant lymph drainage in the upper extremity and upper trunk region: evaluation of lymph drainage in patients with skin melanomas.

Authors:  Toshihiko Hayashi; Hiroshi Furukawa; Akihiko Oyama; Emi Funayama; Akira Saito; Yuhei Yamamoto
Journal:  Int J Clin Oncol       Date:  2012-12-08       Impact factor: 3.402

9.  Wound complications after inguinal lymph node dissection for melanoma: is ACS NSQIP adequate?

Authors:  Carly E Glarner; David Y Greenblatt; Robert J Rettammel; Heather B Neuman; Sharon M Weber
Journal:  Ann Surg Oncol       Date:  2013-01-22       Impact factor: 5.344

Review 10.  [Malignant head and neck melanoma: Part 2: Therapy].

Authors:  C Pföhler; T Vogt; C S L Müller
Journal:  HNO       Date:  2015-08       Impact factor: 1.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.